Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction

Atsuko Kato1, Eugénie Riesenkampff1, Deane Yim1

  • 1Division of Cardiology, The Labatt Family Heart Centre, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Children after the Fontan operation with a single right ventricle (SRV) show increased myocardial fibrosis. This condition is linked to reduced heart muscle contractility, indicating potential long-term risks.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Imaging

Background:

  • Patients with single ventricle (SV) circulations face risks of ventricular dysfunction.
  • The Fontan operation is a palliative procedure for complex congenital heart defects.

Purpose of the Study:

  • To investigate myocardial fibrosis and dysfunction in children post-Fontan operation.
  • To assess cardiac magnetic resonance (CMR) T1 relaxometry and extracellular volume fraction (ECV) in these patients.

Main Methods:

  • Retrospective study of children after Fontan operation undergoing CMR T1 relaxometry.
  • Comparison of native T1 times and ECV in the dominant ventricle with healthy controls.
  • Correlation of T1 and ECV with hemodynamic and clinical parameters.

Main Results:

  • Single right ventricle (SRV) patients exhibited higher T1 and ECV compared to controls and single left ventricle (SLV) patients.
  • No significant difference in T1 and ECV was observed between SLV patients and controls.
  • Age at bidirectional cavopulmonary connection correlated with T1; blood pressure and body weight inversely correlated with ECV.

Conclusions:

  • Fontan patients with SRV demonstrate increased CMR markers of diffuse myocardial fibrosis.
  • These fibrosis markers are associated with decreased myocardial contractility.
  • Further research is needed to determine if increased fibrosis poses greater long-term risks.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
973
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
677